International Diabetes Federation: a consensus on Type 2 diabetes prevention
Open accessAbstract
Aims Early intervention and avoidance or delay of progression to Type 2 diabetes is of enormous benefit to patients in terms of increasing life expectancy and quality of life, and potentially in economic terms for society and health‐care payers. To address the growing impact of Type 2 diabetes the International Diabetes Federation (IDF) Taskforce on Prevention and Epidemiology convened a consensus workshop in 2006. The primary goal of the workshop and this document was the prevention of Type 2 diabetes in both the developed and developing world. A second aim was to reduce the risk of cardiovascular disease in people who are identified as being at a higher risk of Type 2 diabetes. The IDF plan for prevention of Type 2 diabetes is based on controlling modifiable risk factors and can be divided into two target groups: People at high risk of developing Type 2 diabetes The entire population. Conclusions In planning national measures for the prevention of Type 2 diabetes, both groups should be targeted simultaneously with lifestyle modification the primary goal through a stepwise approach. In addition, it is important that all activities are tailored to the specific local situation. Further information on the prevention of diabetes can be found on the IDF website: http://www.idf.org/prevention .
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Early intervention is critical to improve the progression of complications and reduce the long-term cost of diabetes.
“Early intervention has been shown to be critical to improve the progression of the complications and reduce the cost of the disease in the long term [7].”
From A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults (2015) · cites this paper as [7]
The IDF strategy for diabetes prevention section says early detection and intervention can reduce the incidence of diabetes and its complications. The Health economics section describes economic benefits as potential and says long-term cost savings from avoided complications are not yet established by follow-up data. The claim overstates the evidence by presenting a reduction in long-term costs as demonstrated. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPCOS is identified by the International Diabetes Federation as an independent risk factor for type 2 diabetes.
“PCOShasbeenidentified by the International Diabetes Federation as an independent risk factor for DM2 (Alberti et al. , 2007); hence the role of metformin and lifestyle in preventing DM2 in PCOS is highly relevant.”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Alberti et al. , 2007
The Causes of diabetes and Other risk factors sections discuss type 2 diabetes risk factors, but the available passages do not mention PCOS or identify it as an independent risk factor. Searches for “PCOS,” “polycystic,” and “polycystic ovarian syndrome” found no such statement; the indexed copy of Table 1 contains only its heading and a partial header. (LLM, conf=0.70)
Experimental — accuracy not yet measuredPCOS is listed by the International Diabetes Federation as a non-modifiable risk factor for DM2.
“In this context, PCOS is listed by the International Diabetes Federation as a non-modifiable risk factor for DM2. 106”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works
Self-citationAlberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · see citing works
Self-citationThe World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,051 · see citing works
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · see citing works
Self-citationPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320 · see citing works
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901 · see citing works
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · see citing works
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543 · see citing works
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915 · see citing works
Hu, F. B., Li, T. Y., Colditz, G. A., Willett, W. C., & Manson, J. E. (2003) · JAMA · doi:10.1001/jama.289.14.1785 · Cited by 1,892 · see citing works
Lindström, J., & Tuomilehto, J. O. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.725 · Cited by 1,889 · see citing works
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881 · see citing works
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848 · see citing works
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808 · see citing works
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · see citing works
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · see citing works
Effect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344 · see citing works
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339 · see citing works
Abdominal Adiposity and Coronary Heart Disease in Women
Rexrode, K. M. (1998) · JAMA · doi:10.1001/jama.280.21.1843 · Cited by 1,202 · see citing works
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143 · see citing works
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092 · see citing works
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey
Ramachandran, A., Snehalatha, C., Kapur, A., Viswanathan, V., Mohan, V., Das, A. K., Rao, P. V., Yajnik, C. S., KUMAR, K. M. P., & Nair, J. D. (2001) · Diabetologia · doi:10.1007/s001250100627 · Cited by 860 · see citing works
Physical Activity and Television Watching in Relation to Risk for Type 2 Diabetes Mellitus in Men
Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.12.1542 · Cited by 828 · see citing works
International Textbook of Diabetes Mellitus
(2003) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 741 · see citing works
Scheen, A. J., Finer, N., Hollander, P. A., Jensen, M. D., & Gaal, L. F. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 729 · see citing works
[The Da Qing IGT and Diabetes study].
Ayame, H. (2005) · PubMed · Cited by 658 · see citing works
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
Kosaka, K., Noda, M., & Kuzuya, T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.010 · Cited by 656 · see citing works
Kaprio, J. A., Tuomilehto, J., Koskenvuo, M., Romanov, K., Reunanen, A., Eriksson, J. G., Stengård, J., & Kesäniemi, Y. A. (1992) · Diabetologia · doi:10.1007/bf02221682 · Cited by 642 · see citing works
Knowler, W. C., Bennett, P. H., Hamman, R. F., & Miller, M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112648 · Cited by 601 · see citing works
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
Boyko, E. J., Fujimoto, W. Y., Leonetti, D. L., & Newell‐Morris, L. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.465 · Cited by 580 · see citing works
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474 · see citing works
Abuissa, H. S., Jones, P. G., Marso, S. P., & O’Keefe, J. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.051 · Cited by 449 · see citing works
Eriksson, J., Lindström, J., Valle, T., Aunola, S., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Lauhkonen, M., Lehto, P., et al. (1999) · Diabetologia · doi:10.1007/s001250051229 · Cited by 368 · see citing works
Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1321 · Cited by 358 · see citing works
Saaristo, T., Peltonen, M., Lindström, J., Saarikoski, L. A., Sundvall, J., Eriksson, J. G., & Tuomilehto, J. O. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.011 · Cited by 329 · see citing works
A Risk Score for Predicting Incident Diabetes in the Thai Population
Aekplakorn, W., Bunnag, P., Woodward, M., Sritara, P., Cheepudomwit, S., Yamwong, S., Yipintsoi, T., & Rajatanavin, R. (2006) · Diabetes Care · doi:10.2337/dc05-2141 · Cited by 275 · see citing works
Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2518 · Cited by 262 · see citing works
Dunstan, D. W., Salmon, J., Owen, N., Armstrong, T., Zimmet, P. Z., Welborn, T. A., Cameron, A. J., Dwyer, T., Jolley, D., Shaw, J. E., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2603 · Cited by 250 · see citing works
Self-citationDowse, G. K., Gareeboo, H., Alberti, K. G. M. M., Zimmet, P., Tuomilehto, J., Purran, A., Fareed, D., Chitsono, P., Collins, V. R., & Hemraj, F. (1995) · BMJ · doi:10.1136/bmj.311.7015.1255 · Cited by 241 · see citing works
Self-citationManuel, D. G., & Schultz, S. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.407 · Cited by 148 · see citing works
Palmer, A. J., Roze, S., Valentine, W. J., Spinas, G. A., Shaw, J. E., & Zimmet, P. Z. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90029-x · Cited by 128 · see citing works
Self-citationUusitalo, U., Feskens, E. J. M., Tuomilehto, J., Dowse, G., Haw, U., Fareed, D., Hemraj, F., Gareeboo, H., Alberti, K. G. M. M., & Zimmet, P. (1996) · BMJ · doi:10.1136/bmj.313.7064.1044 · Cited by 115 · see citing works
Self-citationO’Dea, K., Patel, M. S., Kubisch, D., Hopper, J. L., & Traianedes, K. (1993) · Diabetes Care · doi:10.2337/diacare.16.7.1004 · Cited by 113 · see citing works
Leahy, J. L., & Kennedy, L. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70034-9 · Cited by 100 · see citing works
Predicting the Development of Diabetes in Older Adults
Kanaya, A. M., Wassel-Fyr, C. L., de Rekeneire, N., Shorr, R. I., Schwartz, A. V., Goodpaster, B. H., Newman, A. B., Harris, T. B., & Barrett-Connor, E. L. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.404 · Cited by 96 · see citing works
Zimmet, P., King, H., Taylor, R. J., Raper, L., Balkau, B., Borger, J., Heriot, W. J., & Thoma, K. (1984) · PubMed · Cited by 83 · see citing works
Self-citationPathophysiology of impaired pulsatile insulin release
Bergsten, P. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3 · Cited by 69 · see citing works
Simmons, R. K., Harding, A.-H., Jakes, R. W., Welch, A., Wareham, N. J., & Griffin, S. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0163-1 · Cited by 69 · see citing works
Davis, W. A., Knuiman, M. W., Hendrie, D. V., & Davis, T. M. E. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01014.x · Cited by 37 · see citing works
Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus
Tuomilehto, J. O., Rastenytė, D., Qiao, Q., & Jakovljević, D. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1002 · Cited by 25 · see citing works
Genetic epidemiology of non‐insulin‐dependent diabetes
Valsania, P., & Micossi, P. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100404 · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Hu F, Manson J, Stampfer M. Diet, lifestyle and the risk of type 2 dia- betes mellitus in women. New Engl J Med 2001; 345: 790-797.
- Eriksson K, Lindgrade F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercises. Diabetologia 1991; 34: 891-898.
- Chiasson J, Gomis R, Hanefeld M, Josse R, Karasik A, Laakso M, for The STOP-NIDMM Trial Research Group. Acarbose for preven- tion of type 2 diabetes mellitus: the STOP-NIDMM randomized trial. Lancet 2002; 359: 2072-77.
- Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · see citing works
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · see citing works
The IMAGE Study Group, Greaves, C. J., Sheppard, K. E., Abraham, C., Hardeman, W., Roden, M., Evans, P. H., & Schwarz, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-119 · Cited by 1,163 · see citing works
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145 · see citing works
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · see citing works
Piepoli, M. F., Corrà, U., Benzer, W., Bjarnason-Wehrens, B., Dendale, P., Gaita, D., McGee, H., Mendes, M., Niebauer, J., Zwisler, A.-D. O., et al. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283313592 · Cited by 796 · see citing works
Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705 · see citing works
Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
Martínez-González, M. Á., Fuente-Arrillaga, C. D. L., Nunez-Cordoba, J. M., Basterra-Gortari, F. J., Beunza, J. J., Vazquez, Z., Benito, S., Tortosa, A., & Bes-Rastrollo, M. (2008) · BMJ · doi:10.1136/bmj.39561.501007.be · Cited by 517 · see citing works
Non-Invasive Blood Glucose Monitoring Technology: A Review
Tang, L., Chang, S. J., Chen, C.-J., & Liu, J.-T. (2020) · Sensors · doi:10.3390/s20236925 · Cited by 481 · see citing works
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384 · see citing works
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379 · see citing works
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362 · see citing works
Lam, B. C. C., Koh, G. C. H., Chen, C., Wong, M. T. K., & Fallows, S. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122985 · Cited by 338 · see citing works
Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies
Tong, X., Dong, J.-Y., Wu, Z.-W., Li, W., & Qin, L.-Q. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.62 · Cited by 337 · see citing works
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334 · see citing works
Metformin therapy and clinical uses
Scarpello, J. H., & Howlett, H. C. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.027 · Cited by 318 · see citing works
Kawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., & Kaku, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60222-1 · Cited by 303 · see citing works
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287 · see citing works
Van Rhoon, L., Byrne, M., Morrissey, E., Murphy, J., & McSharry, J. (2020) · DIGITAL HEALTH · doi:10.1177/2055207620914427 · Cited by 182 · see citing works
Itsiopoulos, C., Brazionis, L., Kaimakamis, M., Cameron, M., Best, J. D., O’Dea, K., & Rowley, K. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.005 · Cited by 171 · see citing works
Ferket, B. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.434 · Cited by 134 · see citing works
Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1970 · Cited by 128 · see citing works
Pan, B., Wu, Y., Yang, Q., Ge, L., Gao, C., Xun, Y., Tian, J., & Ding, G. (2019) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12312 · Cited by 99 · see citing works
Fontbonne, A., Diouf, I., Baccara-Dinet, M., Eschwege, E., & Charles, M.-A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.005 · Cited by 53 · see citing works
Atlantis, E., Vogelzangs, N., Cashman, K., & Penninx, B. J. W. H. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70006-x · Cited by 51 · see citing works
Bonn, S. E., Alexandrou, C., Hjörleifsdottir Steiner, K., Wiklander, K., Östenson, C.-G., Löf, M., & Trolle Lagerros, Y. (2018) · BMC Public Health · doi:10.1186/s12889-018-5026-4 · Cited by 48 · see citing works
Levy, J., Cobas, R. A., & Gomes, M. B. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-16 · Cited by 44 · see citing works
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41 · see citing works
A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120382 · Cited by 41 · see citing works
“Early intervention has been shown to be critical to improve the progression of the complications and reduce the cost of the disease in the long term [7].”
BackgroundWinkler, G., Hídvégi, T., Vándorfi, G., Balogh, S., & Jermendy, G. (2013) · Medical Science Monitor · doi:10.12659/msm.883747 · Cited by 36 · see citing works
“indicating that simple, practical, non-invasive, and inexpensive methods are needed to identify individuals at high risk for IGT and diabetes and to limit the proportion of the population requiring diagnostic glucose tolerance tests [25].”
MethodHu, R., Li, Y., Lv, Q., Wu, T., & Tong, N. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.504 · Cited by 32 · see citing works
Amini, L., Mojab, F., Jahanfar, S., Sepidarkish, M., Raoofi, Z., & Maleki-Hajiagha, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102245 · Cited by 30 · see citing works
Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0014 · Cited by 29 · see citing works
Khamseh, M. E., Ansari, M., Malek, M., Shafiee, G., & Baradaran, H. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500228 · Cited by 20 · see citing works
Wang, Y., Feng, Q., Niu, X., Xu, K., Wang, Y., Wang, J., Li, Q., Mao, Y., & Gao, S. (2016) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2016/9417362 · Cited by 16 · see citing works
Digital Health Interventions to Prevent Type 2 Diabetes Mellitus: Systematic Review
Duong, T., Olsen, Q., Menon, A., Woods, L., Wang, W., Varnfield, M., Jiang, L., & Sullivan, C. (2025) · Journal of Medical Internet Research · doi:10.2196/67507 · Cited by 14 · see citing works
Muilwijk, M., Stronks, K., Qureshi, S. A., Beune, E., Celis-Morales, C., Gill, J., Sheikh, A., Jenum, A. K., & van Valkengoed, I. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012783 · Cited by 5 · see citing works
- Authors
- Alberti, K. G. M. M., Zimmet, P., & Shaw, J.
- Affiliations
- St Mary's Hospital (GB)
- Corresponding author
- Alberti, K. G. M. M.
- ORCID
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2007-04-26
- Volume
- 24
- Issue
- 5
- Pages
- 451-463
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2159806894
- Cited by
- 778
- References
- 56
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 31 · 2023: 30 · 2022: 34 · 2021: 33 · 2020: 33 · 2019: 42 · 2018: 44 · 2017: 55 · 2016: 53 · 2015: 56 · 2014: 51 · 2013: 60 · 2012: 67
- FWCI
- 29.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, International Diabetes Federation, consensus recommendations, vulnerable populations, lifestyle modification, cardiovascular risk reduction, modifiable risk factors, diabetes epidemiology
- MeSH terms
- Adult, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Health Education, Health Promotion, Humans, International Cooperation, Male, Middle Aged, Risk Factors, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
